Jiacheng Li , Xiaozhen Liu , Lin Chen , Xinping Zhu , Zhihong Yu , Liyao Dong , Xinyun Zhao , Hongling Zou , Qin Wei , Yongcai Feng , Yongqiang Zhu , Kequn Chai , Qun Li , Mingqian Li
{"title":"“离子通道调节剂异海松酸调节钙和氧化磷酸化途径抑制乳腺癌的增殖和转移”[j].中国药理学杂志,2023,42(2):116415。","authors":"Jiacheng Li , Xiaozhen Liu , Lin Chen , Xinping Zhu , Zhihong Yu , Liyao Dong , Xinyun Zhao , Hongling Zou , Qin Wei , Yongcai Feng , Yongqiang Zhu , Kequn Chai , Qun Li , Mingqian Li","doi":"10.1016/j.taap.2025.117311","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23174,"journal":{"name":"Toxicology and applied pharmacology","volume":"499 ","pages":"Article 117311"},"PeriodicalIF":3.3000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis” [Toxicology and applied Pharmacology, 2023, 462:116415]\",\"authors\":\"Jiacheng Li , Xiaozhen Liu , Lin Chen , Xinping Zhu , Zhihong Yu , Liyao Dong , Xinyun Zhao , Hongling Zou , Qin Wei , Yongcai Feng , Yongqiang Zhu , Kequn Chai , Qun Li , Mingqian Li\",\"doi\":\"10.1016/j.taap.2025.117311\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23174,\"journal\":{\"name\":\"Toxicology and applied pharmacology\",\"volume\":\"499 \",\"pages\":\"Article 117311\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicology and applied pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0041008X25000870\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology and applied pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041008X25000870","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Corrigendum to “Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis” [Toxicology and applied Pharmacology, 2023, 462:116415]
期刊介绍:
Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.
Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.
Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.